Skip to contentLirea is launching soon. Join the waitlist to be notified.

Peptide blend tracker

Research blend

Wolverine tracker

Your Wolverine blend, on your device: BPC-157 and TB-500 in one.

Wolverine is a recovery blend of BPC-157 and TB-500 in a single vial. Lirea tracks each one as its own peptide, so your running totals stay honest, encrypted on your device, with no copy at our end.

One email on launch day, and nothing else. The app itself never asks for one.

Today

On your schedule

This week

Wolverine

on schedule

Logged

Weight check-in

trend
Log a dose

What's in it

Wolverine is a blend of 2 peptides.

One injection, several compounds. Lirea tracks each of them as its own peptide, so a shared ingredient never gets double-counted across your protocol and the running totals stay honest.

Not the blend in your fridge?

Vendors invent blends faster than anyone can catalogue them, and yours may not match a named mix at all. Wolverine is free to track at full depth, and so is telling Lirea exactly how many milligrams of each peptide your own vial holds, because two vials of the same blend rarely agree. Pro adds the other direction: defining a blend that isn’t in the library, from whatever is actually in it.

What you'll track

Made for how you actually take Wolverine.

A reconstituted subcutaneous injection from a single combined vial.

Both components, tracked properly

Track BPC-157 and TB-500 as the separate peptides they are, so your running totals stay right rather than hiding inside one blend entry.

No accidental double-dosing

If you also run BPC-157 or TB-500 on their own, keeping them separate is what stops a shared peptide being counted twice across your protocol.

Cycle and reconstitution, handled

Lirea does the reconstitution math, counts your doses remaining, and keeps track of where you are in the cycle.

Recovery in context

Log how recovery and soreness track against your doses, privately.

Pen & vial inventory

A combined vial holds several doses. Lirea tracks doses remaining and your reconstitution date, and breaks the total down per peptide.

Why Lirea

Your Wolverine data is nobody's business but yours.

No employer, insurer, or wellness platform ever sees what you log, and neither do we. It's stored and encrypted on your device, with no account and no server in the middle.

How your data stays yours
  • No account

    Open the app and start. We never ask who you are.

  • On-device

    Your data is stored and encrypted on your phone.

  • No analytics SDKs

    No Firebase, no trackers, no ad networks.

  • Check it yourself

    Turn on airplane mode. Everything but the paywall still works, because there is nothing on the other end.

Questions

Wolverine, tracked privately

What's in the Wolverine blend?

BPC-157 and TB-500 in one vial. (Note: some sellers reuse the "Wolverine" name for a larger four-peptide blend, always check the components, not just the name.)

How does Lirea track a blend?

As one product with several components: you log a single dose, and Lirea accumulates each peptide's amount from the ratio you set, including across any standalone vials you also run.

Does Lirea recommend a Wolverine dose?

No. Lirea is a private tracker, not medical advice, and these peptides are not FDA-approved medications. It records whatever you choose; decisions are between you and a qualified clinician.

Related trackers

Lirea is a private tracking tool, not a medical device, a pharmacy, or a source of medical advice. Anything shown here is general reference, not a recommendation. Many peptides are not approved by the FDA and are sold for research use only; Lirea neither sells nor supplies any compound. Always follow the guidance of a qualified healthcare provider.

Launching soon

Keep it, and keep it yours.

Track your weekly dose, your titration, and how you’re feeling, all on your device. No account required. Be first to know when Lirea is live.

One email at launch. No spam, unsubscribe anytime. This list is separate from the app, and we never receive your health data. Privacy.

App Store, soonGoogle Play, soon